prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Her2, Specimen #: Race: BLACK. Physician (s) : SPECIMEN: A: LEFT BREAST LUMPECTOMY B: SENTINEL LYMPH NODE #1. C: NON-SENTINEL LYMPH NODE D: SENTINEL LYMPH NODE #2. E: ADDITIONAL LEFT BREAST INFERIOR MARGIN. FINAL DIAGNOSIS: A. BREAST, LEFT, LUMPECTOMY: INFILTRATING DUCTAL CARCINOMA, HIGH GRADE, NOTTINGHAM SCORE 9/9. TUMOR SIZE = 2.5 CM (MEASURED GROSSLY). INVASIVE CARCINOMA WITHIN 1 MM OF THE ANTERIOR (YELLOW INK) MARGIN. (SLIDE A20). DUCTAL CARCINOMA IN-SITU, COMEDO-TYPE. FOCUS OF DUCTAL CARCINOMA IN-SITU, COMEDO-TYPE WITHIN 1.3 MM OF THE. INFERIOR (GREEN INK) MARGIN (SLIDE A18) . NEGATIVE FOR LYMPH VASCULAR SPACE INVASION. FIBROCYSTIC CHANGES INCLUDING FIBROSIS AND APOCRINE METAPLASIA. AJCC PATHOLOGIC STAGE: pT2 NO (i-) Mx. B. SENTINEL LYMPH NODE #1, EXCISION: ONE LYMPH NODE NEGATIVE FOR TUMOR BY H AND E AND IMMUNOHISTOCHEMSTRY. C. NON-SENTINEL LYMPH NODE, EXCISION: ONE LYMPH NODE NEGATIVE FOR TUMOR. D. SENTINEL LYMPH NODE #2, EXCISION: NO LYMPHOID TISSUE IDENTIFIED. E. BREAST, LEFT, ADDITIONAL INFERIOR MARGIN, EXCISION: FIBROCYSTIC CHANGES INCLUDING FIBROSIS AND APOCRINE METAPLASIA. NEGATIVE FOR TUMOR. Specimen # : CLINICAL DIAGNOSIS AND HISTORY: -year-old female with IDC. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated "LEFT BREAST LUMPECTOMY" consists of a fibroratty tissue. fragment, oriented with sutures (long is lateral, short is superior). measuring 8.2 cm medial to lateral, 7.: cm superior to inferior, and 2.7. cm anterior to posterior. Ink code: Red=medial and lateral, blue=superior,. green=inferior, yellow=anterior, black=posterior. Sectioning from medial. to lateral reveals a well-defined, irregular, tan tumor in the. anterior/inferior portion of the specimen, measuring 2.5 x 1.5 x 1.5 cm in. greatest dimension. The tumor is within 2.0 mm of the anterior margin. The. remaining tissue is mostly fatty with patches of dense, fibrous tissue,. especially lateral to the tumor. One section of the tumor, and one section. of the grossly normal fibrous tissue (2.0 cm lateral to tumor) submitted. for the CBCP protocol with matching paraffin section in cassettes A1-A3,. respectively. The specimen is submitted from medial to lateral,. concentrating on the fibrous areas. Cassette summary: A6-A7: One paired slice. A10-A11: One paired slice, from which blocks A1 and A2 were taken. A12-A13: : Paired slices. A14-A15: Paired slices. A18-A19: One paired slice together. A23: Lateral most portion of specimen. B. Received in formalin, labeled with the patient's name,. B, designated "SENTINEL LYMPH NODE #1" consists of a single lymph node. measuring 0.9 x 0.5 x 0.4 cm. The lymph node is bisected and half is. submitted for the CBCP protocol. The remainder is submitted for permanent. section. C. Received in formalin, labeled with the patient's name,. B, designated "NON-SENTINEL LYMPH NODE" consists of a fragment of. yellow/tan fibroadipose tissue, 2.5 x 0.6 x 0.3 cm. One potential lymph. node candidate is identified, measuring 0.5 cm in greatest dimension. The. specimen is entirely submitted. D. Received in formalin, labeled with the patient's name,. B, designated "SENTINEL LYMPH NODE #2" consists of a fragment OL pink/tan. to yellow fibroadipose tissue, 2.6 x 1.6 x 0.9 cm. The specimen is. bisected revealing mottled, pink/tan to red cut surfaces. The specimen is. Specimen #: GROSS DESCRIPTION (continued) : entirely submitted. E. Received in formalin, labeled with the patient's name,. B, designated "ADDITIONAL LEFT BREAST INFERIOR MARGIN" consists of a. fragment of fibroadipose tissue, 2.1 x 1.5 x 0.8 cm. The specimen is not. oriented and is inked blue and serially sectioned. The cut surfaces reveal. yellow/tan adipose tissue admixed with bands of white, fibrous tissue. There is a focus of pink/white, firmer tissue measuring 0.5 cm in greatest. dimension. The specimen is entirely submitted.

expanded version (tokens=1535) : 
 Histological classification: Infiltrating ductal carcinoma, high grade, Nottingham score 9/9. Ductal carcinoma in-situ, comedo-type.

Subtype: Her2

Size of tumor: 2.5 cm (measured grossly)

Margins involvement: Invasive carcinoma within 1 mm of the anterior (yellow ink) margin. Focus of ductal carcinoma in-situ, comedo-type within 1.3 mm of the inferior (green ink) margin.

Necrosis: None mentioned.

Infiltrating lymphocytes: Not mentioned.

Histological grade: High grade.

Nuclear grade: Not mentioned.

Lymphovascular invasion: Negative for lymphovascular space invasion.

Calcification: Not mentioned.

Receptor status: Her2 positive.

IHC: Immunohistochemistry testing was performed on the sentinel lymph node #1, which was negative for tumor. No other ancillary testing results were mentioned. 

Other findings: Fibrocystic changes including fibrosis and apocrine metaplasia were noted in several areas. Additionally, the report indicates that one non-sentinel lymph node was negative for tumor. The AJCC pathologic stage was pT2 NO (i-) Mx.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1690) : 
 The patient, a black woman, was diagnosed with Her2 subtype infiltrating ductal carcinoma of the left breast. High-grade tumor measuring 2.5 cm grossly, with invasive carcinoma within 1 mm of the anterior margin and comedo-type ductal carcinoma in-situ within 1.3mm of the inferior margin. Negative for lymphovascular space invasion and positive for Her2 receptor status. The AJCC pathologic stage indicated pT2 NO (i-) Mx and one sentinel lymph node was negative for tumor.

